Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines.
about
The role of transforming growth factor β1 in the regulation of blood pressurePhosphorylation of GATA-4 is involved in alpha 1-adrenergic agonist-responsive transcription of the endothelin-1 gene in cardiac myocytesTemporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytesRelease of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction.Angiogenesis in cancer: the role of endothelin-1.Regulation of apoptosis by vasoactive peptides.Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis.Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growthThe autonomous growth of human papillomavirus type 16-immortalized keratinocytes is related to the endothelin-1 autocrine loop.Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy.Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts.Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism.Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells.Tumor-evoked sensitization of C nociceptors: a role for endothelinSalvianolic Acid A, as a Novel ETA Receptor Antagonist, Shows Inhibitory Effects on Tumor in VitroTargeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.Zibotentan for the treatment of castrate-resistant prostate cancer.Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension.Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS factors.Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity.Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans.The inhibitory effect of miRNA-1 on ET-1 gene expression.Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.Therapeutic use and perspectives of synthetic peptides in oncology.Stimulation of colorectal cancer cell line growth by ET-1 and its inhibition by ET(A) antagonists.SRC family kinases mediate epithelial Na+ channel inhibition by endothelin.Calcineurin-GATA4 pathway is involved in beta-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes.Ca(2+) channels activated by endothelin-1 in CHO cells expressing endothelin-A or endothelin-B receptors.Endothelin converting enzyme-1 expression in endometrial adenocarcinomas.Effects of nonselective cation channels and PI3K on endothelin-1-induced PYK2 tyrosine phosphorylation in C6 glioma cells.Cellular dielectric spectroscopy: a powerful new approach to label-free cellular analysis.Cytoprotective effects of endothelin-1 on mesenchymal stem cells: an in vitro study.Increase in immunoreactivity for endothelin-1 in blood vessels of rat liver metastases: experimental sarcoma and carcinoma.Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells.The endothelin system in human glioblastoma.
P2860
Q26998564-9CB78429-98DD-41B4-B00B-9F79C6918179Q28378062-BA64D8B6-0E9E-4EC9-82CD-3641CBA6085EQ30481880-0DFC57C3-14B7-47C8-9D60-25A6512AB49DQ33674255-A0B999A8-48BF-442B-9B88-3ADCFF9F3511Q33822741-285FF4EF-7D71-4874-B76D-BDAC043B6EF8Q34369962-EB1D2467-2F50-4DDA-A53F-AB0C27ADEC92Q35242640-D59039B0-BFDC-4D24-8B81-00E591D7920CQ35765074-62651DC0-32C2-4323-9CE2-8A9C8D5DD02EQ35892290-173FF97D-1505-44B8-BE13-DFAB18EF5F8EQ35975832-ACC420AC-4BF5-4590-A3FE-A3252DF243E6Q36080476-BF440A61-0293-462D-971A-0AEA7F8D8FC6Q36623288-5CFE1003-D233-44A6-B252-B1F64553F11DQ36646644-87B17288-4E3A-4384-9147-394C71CC7DDBQ36956936-8B09FA09-CF36-4D44-859D-16D615D1CED2Q37209951-53206BF3-4E0A-4F3F-B8F8-40EEE95F2137Q37485865-4AB931D6-EF72-421A-AD74-B3643B751364Q37760222-202B9E17-A666-49F8-BC2C-ECAA0A8A77CDQ38225794-1888F016-832E-4BEC-9BB1-42A70846DFA0Q38360604-D7C4970E-D5E7-493B-80B2-7632269FE6BBQ38751536-42AFB418-6A66-4354-AA54-76D4518BF9A9Q39039151-67810854-A41D-4150-9ED9-AF3D0AB1EE54Q39351872-FE46928E-1F69-49FF-8D15-F8235D55B563Q40304029-FB32FD8D-A1B3-4813-99AB-041C4DA43105Q40332979-B1E543B5-DE9D-4644-8C8B-27C9D4E9C966Q40710996-5885FFF4-A2C9-45DF-B5DA-E97AC7AA7C87Q40848540-7410C28A-9E81-453A-8C83-EB51D8DC2E69Q42510249-3C8C3F0B-D555-4F02-8A14-8E729EF129D8Q43660529-81A0D5DA-D488-48AA-B083-986817EC8438Q43766350-3AF21FD7-7D00-4F9A-890C-011E02DBC0E8Q43840229-DB89BD83-61A4-4F06-950D-A30410A869A7Q44538201-96E27E7F-79FA-42B9-AE9D-477FC795F48AQ45081519-53DAE249-63AC-40BE-806B-50C55A59D923Q47873444-C5F1383E-7917-4F45-84A4-77A22076D368Q52193145-48C6B622-18A7-430E-80C2-1877C65DE63DQ53750044-6A6196AB-5DE1-43B5-A5BF-1FC4712C2B2AQ55474920-C4CC260D-B0BC-4783-84EF-F5643F935E62
P2860
Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines.
@en
type
label
Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines.
@en
prefLabel
Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines.
@en
P2093
P2860
P356
P1476
Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines.
@en
P2093
Nakajima T
Shichiri M
Yanagisawa M
P2860
P304
P356
10.1172/JCI115210
P407
P577
1991-05-01T00:00:00Z